1.1 List of Tables 5
1.2 List of Figures 7

2 Introduction 8
2.1 What Is This Report About? 8
2.2 Diabetes Care Devices Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 9

3 Diabetes Care Devices Market, United States 11
3.1 Diabetes Care Devices Market, United States, Revenue ($m), 2015-2025 11
3.2 Diabetes Care Devices Market, United States, Revenue Mix ($m), 2019 13
3.3 Diabetes Care Devices Market, United States, Category Contribution by Revenue ($m), 2019 14
3.4 Diabetes Care Devices Market, United States, Revenue ($m), 2015-2025 15
3.5 Diabetes Care Devices Market, United States, Volume (Units), 2015-2025 17
3.6 Diabetes Care Devices Market, United States, Volume (Units), 2015-2025 19
3.7 Diabetes Care Devices Market, United States, Company Share by Revenue ($m), 2019 21

4 Glucose Monitoring Market, United States 23
4.1 Glucose Monitoring Market, United States, Revenue ($m), 2015-2025 23
4.1.1 Blood Glucose Meters Market, United States, Revenue ($m), by Segment, 2015-2025 25
4.2 Glucose Monitoring Market, United States, Volume (Units), 2015-2025 27
4.2.1 Blood Glucose Meters Market, United States, Volume (Units), by Segment, 2015-2025 29
4.3 Glucose Monitoring Market, United States, Average Price ($) , 2015-2025 31
4.4 Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), 2019 32
4.5 Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2019 33

5 Insulin Delivery Market, United States 34
5.1 Insulin Delivery Market, United States, Revenue Mix ($m), 2019 34
5.2 Insulin Delivery Market, United States, Segment Contribution (%), 2019 35
5.3 Insulin Delivery Market, United States, Revenue ($m), 2015-2025 36
5.3.1 Insulin Pens Market, United States, Revenue ($m), by Segment, 2015-2025 38
5.3.2 Insulin Pumps Market, United States, Revenue ($m), by Segment, 2015-2025 40
5.4 Insulin Delivery Market, United States, Volume (Units), 2015-2025 42
5.4.1 Insulin Pens Market, United States, Volume (Units), by Segment, 2015-2025 44
5.4.2 Insulin Pumps Market, United States, Volume (Units), by Segment, 2015-2025 46
5.5 Insulin Delivery Market, United States, Average Price ($), 2015-2025 48
5.6 Insulin Delivery Market, United States, Distribution Share by Revenue ($m), 2019 49
5.7 Insulin Delivery Market, United States, Company Share by Revenue ($m), 2019 50

6 Overview of Key Companies in United States, Diabetes Care Devices Market 52
6.1 DexCom Inc 52
6.1.1 Company Overview 52
6.2 Medtronic Plc 52
6.2.1 Company Overview 52
6.3 Novo Nordisk AS 52
6.3.1 Company Overview 52
6.4 Eli Lilly and Co 53
6.4.1 Company Overview 53
6.5 Abbott Laboratories 53
6.5.1 Company Overview 53
6.6 Sanofi 53
6.6.1 Company Overview 53
6.7 Insulet Corp 54
6.7.1 Company Overview 54

7 Diabetes Care Devices Market Pipeline Products 55

8 Financial Deals Landscape 56
8.1 Acquisition 56
8.1.1 CCS Medical Holdings May Sell Itself 56
8.1.2 KNOW Bio Acquires Clinical Sensors 58
8.1.3 Medtronic Acquires Klue 59
8.1.4 Cerecor Acquires Aevi Genomic Medicine 60
8.1.5 Dare Bioscience Acquires Microchips Biotech 62
8.1.6 Best Buy Acquires Critical Signal Technologies 64
8.2 Debt Offerings 65
8.2.1 Thermo Fisher Scientific Prices Public Offering of 2.375% Notes Due 2032 for USD668 Million 65
8.2.2 Thermo Fisher Scientific Prices Public Offering of 1.750% Notes Due 2027 for USD668 Million 67
8.2.3 Pfizer Raises USD1.25 Billion in Public Offering of 2.625% Notes Due 2030 69
8.2.4 Thermo Fisher Scientific Prices Public Offering of 4.133% Notes Due 2025 for USD1.1 Billion 71
8.2.5 Thermo Fisher Scientific Prices Public Offering of 4.497% Notes Due 2030 for USD1.1 Billion 73
8.2.6 Guided Therapeutics Raises USD0.7 Million in Public Offering of Convertible Note 75
8.2.7 Eli Lilly Prices Public Offering of 0.625% Notes Due 2031 for USD665.5 Million 76
8.2.8 Eli Lilly Prices Public Offering of 1.7% Notes Due 2049 for USD1.1 Billion 78
8.2.9 Thermo Fisher Scientific Raises USD990 Million in Public Offering of 1.500% Notes Due 2039 80
8.2.10 Thermo Fisher Scientific Raises USD900 Million in Public Offering of 2.600% Notes Due 2029 83
8.2.11 Thermo Fisher Scientific Raises USD1.1 Billion in Public Offering of 1.875% Notes Due 2049 85
8.2.12 Thermo Fisher Scientific Raises USD880 Million in Public Offering of 0.500% Notes Due 2028 88
8.2.13 Thermo Fisher Scientific Raises USD990 Million in Public Offering of 0.875% Notes Due 2031 91
8.2.14 Thermo Fisher Scientific Raises USD880 Million in Public Offering of 0.125% Notes Due 2025 94
8.2.15 Insulet Raises USD800 Million in 0.375% Convertible Senior Notes Due 2026 97
8.2.16 Senseonics Holdings Raises USD82 Million in Private Placement of 5.25% Notes Due 2025 99
8.2.17 Becton Dickinson Raises USD669.7 Million in Public Offering of 0.174% Notes Due 2021 100
8.2.18 Becton Dickinson Raises USD669.7 Million in Public Offering of 1.208% Notes Due 2026 102
8.2.19 Becton Dickinson Raises USD893 Million in Public Offering of 0.632% Notes due 2023 104
8.3 Equity Offerings 106
8.3.1 Tenax Therapeutics Prices Private Placement of Shares and Warrants for USD2.8 Million 106
8.3.2 Xeris Pharma Raises USD42.7 Million in Public Offering of Shares 107
8.3.3 Albireo Pharma Raises USD46 Million in Public Offering of Shares 109
8.3.4 Guided Therapeutics Raises USD0.7 Million in Private Placement of Units 111
8.3.5 PhysioLogic Devices Raises Funds through Financing 112
8.3.6 Senseonics Plans to Raise up to USD50 Million in Public Offering of Shares 113
8.3.7 Organogenesis Prices USD45 Million Public Offering of Shares 114
8.3.8 Organogenesis Plans to Raise up to USD100 Million in Public Offering of Securities 116
8.3.9 Xeris Pharma Plans to Raise up to USD50 Million in Public Offering of Shares 117
8.3.10 Valeritas Holdings Plans to Raise up to USD10.7 Million in Public Offering of Shares 118
8.3.11 Senseonics Holdings Raises USD25 Million in Public Offering of Shares 119
8.3.12 Glucose Biosensor Systems Files Registration Statement for IPO of Shares 121
8.3.13 MannKind to Raise up to USD50 Million in Public Offering of Shares 122
8.3.14 Dance Biopharm Raises USD20.5 Million in Private Placement 124
8.4 Partnerships 125
8.4.1 Abbott Labs and Insulet Enter into Partnership 125
8.4.2 Biocorp Production Enters into Agreement with Amalgam Rx (iSage Rx) 126
8.4.3 Senseonics Enters into Partnership with Companion Medical 127
8.4.4 Abbott Labs Enters into Agreement with Bigfoot Biomedical 128
8.4.5 Trividia Health and Mellitus Health Form Partnership 129
8.4.6 Solys Diagnostics Enters into Licensing Agreement with Liquid Sensing 130
8.4.7 Sanofi and Abbott Enter into Partnership 131
8.4.8 Medtronic and Tidepool to Enter into Partnership 132
8.4.9 LifeScan Enters into Distribution Agreement with Sanvita Medical 133
8.5 Private Equity 134
8.5.1 Becton Dickinson Shareholders Reject Mini Tender Offer from TRC Capital 134
8.5.2 Blackstone Group and Cinven May Bid for Smiths Medical 135
8.5.3 AgaMatrix and WaveForm Technologies Raises USD56 Million in Financing 137
8.6 Venture Financing 139
8.6.1 Modular Medical to Raise Funds through Venture Financing 139
8.6.2 Fractyl Labs Raises USD44.8 Million in Venture Financing 140
8.6.3 Bigfoot Biomedical Raises USD45 Million in Initial Tranche of Series C Financing 141
8.6.4 VivaChek Labs Raises USD14.2 Million in Series C Financing 143
8.6.5 Hygieia Raises USD1.3 Million in Venture Financing 144
8.6.6 Eccrine Systems Raises USD1.9 Million in Venture Financing 145
8.6.7 Accessible Diagnostics Raises USD0.2 Million in Venture Financing 146
8.6.8 Amalgam Rx (iSage Rx) Secures USD0.65 Million in Venture Financing 147
8.6.9 MuscleSound Raises USD0.8 Million in Venture Financing 148
8.6.10 Informed Data Systems (One Drop) Raises USD40 Million in Series B Financing 149
8.6.11 TecMed Raises Funds through Venture Financing 150
8.6.12 Thermalin Raises Additional USD12.2 Million in Venture Financing 151
8.6.13 VivaChek Laboratories Raises Funds through Venture Financing 152
8.6.14 POPS! Diabetes Care Secures USD6 Million in Series A Funding 153
8.6.15 Beta Bionics Raises USD63 Million in Series B2 Financing 154
8.6.16 Encellin Raises USD1.6 Million in Venture Financing 156
8.6.17 Eccrine Systems Raises USD0.6 Million in Venture Financing 157
8.6.18 PhysioLogic Devices to Raise USD3 Million in Venture Financing 158
8.6.19 Intuity Medical (Rosedale Medical) Raises USD26.27 Million in Venture Financing 159
8.6.20 Mighty Well Raises Funds through Venture Financing 160

9 Appendix 161
9.1 Research Methodology 162
9.1.1 Coverage 162
9.1.2 Secondary Research 162
9.1.3 Primary Research 163
9.1.4 Market Modeling and Forecasting 163
9.1.5 Company Share Analysis 165
9.1.6 Distribution Share Analysis 165
9.1.7 Benchmarking 166
9.2 GlobalData Consulting 166
9.3 Contact Us 167
9.4 Disclaimer 167

List of Tables
Table 1: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 12
Table 2: Diabetes Care Devices Market, United States, Category Contribution by Revenue ($m), 2019 14
Table 3: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Historic, 2015-2020 16
Table 4: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2021-2025 16
Table 5: Diabetes Care Devices Market, United States, Volume (Units), 2015-2025 18
Table 6: Diabetes Care Devices Market, United States, Volume (Units), Historic, 2015-2020 20
Table 7: Diabetes Care Devices Market, United States, Volume (Units), Forecast, 2021-2025 20
Table 8: Diabetes Care Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2019 22
Table 9: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2015-2020 24
Table 10: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2021-2025 24
Table 11: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, 2015-2020 26
Table 12: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, 2021-2025 26
Table 13: Glucose Monitoring Market, United States, Volume (Units), 2015-2020 28
Table 14: Glucose Monitoring Market, United States, Volume (Units), 2021-2025 28
Table 15: Blood Glucose Meters Market, United States, Volume (Units), 2015-2020 30
Table 16: Blood Glucose Meters Market, United States, Volume (Units), 2021-2025 30
Table 17: Glucose Monitoring Market, United States, Average Price ($), 2015-2020 31
Table 18: Glucose Monitoring Market, United States, Average Price ($), 2021-2025 31
Table 19: Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019 32
Table 20: Glucose Monitoring Market, United States, Company Share by Revenue ($m), USD Constant, 2019 33
Table 21: Insulin Delivery Market, United States, Segment Contribution (%), 2019 35
Table 22: Insulin Delivery Market, United States, Revenue ($m), USD Constant, 2015-2020 37
Table 23: Insulin Delivery Market, United States, Revenue ($m), USD Constant, 2021-2025 37
Table 24: Insulin Pens Market, United States, Revenue ($m), USD Constant, 2015-2020 39
Table 25: Insulin Pens Market, United States, Revenue ($m), USD Constant, 2021-2025 39
Table 26: Insulin Pumps Market, United States, Revenue ($m), USD Constant, 2015-2020 41
Table 27: Insulin Pumps Market, United States, Revenue ($m), USD Constant, 2021-2025 41
Table 28: Insulin Delivery Market, United States, Volume (Units), 2015-2020 43
Table 29: Insulin Delivery Market, United States, Volume (Units), 2021-2025 43
Table 30: Insulin Pens Market, United States, Volume (Units), 2015-2020 45
Table 31: Insulin Pens Market, United States, Volume (Units), 2021-2025 45
Table 32: Insulin Pumps Market, United States, Volume (Units), 2015-2020 47
Table 33: Insulin Pumps Market, United States, Volume (Units), 2021-2025 47
Table 34: Insulin Delivery Market, United States, Average Price ($), 2015-2020 48
Table 35: Insulin Delivery Market, United States, Average Price ($), 2021-2025 48
Table 36: Insulin Delivery Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019 49
Table 37: Insulin Delivery Market, United States, Company Share by Revenue ($m), USD Constant, 2019 51
Table 38: Diabetes Care Devices Market Pipeline Products 55
Table 39: CCS Medical Holdings May Sell Itself 56
Table 40: KNOW Bio Acquires Clinical Sensors 58
Table 41: Medtronic Acquires Klue 59
Table 42: Cerecor Acquires Aevi Genomic Medicine 60
Table 43: Dare Bioscience Acquires Microchips Biotech 62
Table 44: Best Buy Acquires Critical Signal Technologies 64
Table 45: Thermo Fisher Scientific Prices Public Offering of 2.375% Notes Due 2032 for USD668 Million 65
Table 46: Thermo Fisher Scientific Prices Public Offering of 1.750% Notes Due 2027 for USD668 Million 67
Table 47: Pfizer Raises USD1.25 Billion in Public Offering of 2.625% Notes Due 2030 69
Table 48: Thermo Fisher Scientific Prices Public Offering of 4.133% Notes Due 2025 for USD1.1 Billion 71
Table 49: Thermo Fisher Scientific Prices Public Offering of 4.497% Notes Due 2030 for USD1.1 Billion 73
Table 50: Guided Therapeutics Raises USD0.7 Million in Public Offering of Convertible Note 75
Table 51: Eli Lilly Prices Public Offering of 0.625% Notes Due 2031 for USD665.5 Million 76
Table 52: Eli Lilly Prices Public Offering of 1.7% Notes Due 2049 for USD1.1 Billion 78
Table 53: Thermo Fisher Scientific Raises USD990 Million in Public Offering of 1.500% Notes Due 2039 80
Table 54: Thermo Fisher Scientific Raises USD900 Million in Public Offering of 2.600% Notes Due 2029 83
Table 55: Thermo Fisher Scientific Raises USD1.1 Billion in Public Offering of 1.875% Notes Due 2049 85
Table 56: Thermo Fisher Scientific Raises USD880 Million in Public Offering of 0.500% Notes Due 2028 88
Table 57: Thermo Fisher Scientific Raises USD990 Million in Public Offering of 0.875% Notes Due 2031 91
Table 58: Thermo Fisher Scientific Raises USD880 Million in Public Offering of 0.125% Notes Due 2025 94
Table 59: Insulet Raises USD800 Million in 0.375% Convertible Senior Notes Due 2026 97
Table 60: Senseonics Holdings Raises USD82 Million in Private Placement of 5.25% Notes Due 2025 99
Table 61: Becton Dickinson Raises USD669.7 Million in Public Offering of 0.174% Notes Due 2021 100
Table 62: Becton Dickinson Raises USD669.7 Million in Public Offering of 1.208% Notes Due 2026 102
Table 63: Becton Dickinson Raises USD893 Million in Public Offering of 0.632% Notes due 2023 104
Table 64: Tenax Therapeutics Prices Private Placement of Shares and Warrants for USD2.8 Million 106
Table 65: Xeris Pharma Raises USD42.7 Million in Public Offering of Shares 107
Table 66: Albireo Pharma Raises USD46 Million in Public Offering of Shares 109
Table 67: Guided Therapeutics Raises USD0.7 Million in Private Placement of Units 111
Table 68: PhysioLogic Devices Raises Funds through Financing 112
Table 69: Senseonics Plans to Raise up to USD50 Million in Public Offering of Shares 113
Table 70: Organogenesis Prices USD45 Million Public Offering of Shares 114
Table 71: Organogenesis Plans to Raise up to USD100 Million in Public Offering of Securities 116
Table 72: Xeris Pharma Plans to Raise up to USD50 Million in Public Offering of Shares 117
Table 73: Valeritas Holdings Plans to Raise up to USD10.7 Million in Public Offering of Shares 118
Table 74: Senseonics Holdings Raises USD25 Million in Public Offering of Shares 119
Table 75: Glucose Biosensor Systems Files Registration Statement for IPO of Shares 121
Table 76: MannKind to Raise up to USD50 Million in Public Offering of Shares 122
Table 77: Dance Biopharm Raises USD20.5 Million in Private Placement 124
Table 78: Abbott Labs and Insulet Enter into Partnership 125
Table 79: Biocorp Production Enters into Agreement with Amalgam Rx (iSage Rx) 126
Table 80: Senseonics Enters into Partnership with Companion Medical 127
Table 81: Abbott Labs Enters into Agreement with Bigfoot Biomedical 128
Table 82: Trividia Health and Mellitus Health Form Partnership 129
Table 83: Solys Diagnostics Enters into Licensing Agreement with Liquid Sensing 130
Table 84: Sanofi and Abbott Enter into Partnership 131
Table 85: Medtronic and Tidepool to Enter into Partnership 132
Table 86: LifeScan Enters into Distribution Agreement with Sanvita Medical 133
Table 87: Becton Dickinson Shareholders Reject Mini Tender Offer from TRC Capital 134
Table 88: Blackstone Group and Cinven May Bid for Smiths Medical 135
Table 89: AgaMatrix and WaveForm Technologies Raises USD56 Million in Financing 137
Table 90: Modular Medical to Raise Funds through Venture Financing 139
Table 91: Fractyl Labs Raises USD44.8 Million in Venture Financing 140
Table 92: Bigfoot Biomedical Raises USD45 Million in Initial Tranche of Series C Financing 141
Table 93: VivaChek Labs Raises USD14.2 Million in Series C Financing 143
Table 94: Hygieia Raises USD1.3 Million in Venture Financing 144
Table 95: Eccrine Systems Raises USD1.9 Million in Venture Financing 145
Table 96: Accessible Diagnostics Raises USD0.2 Million in Venture Financing 146
Table 97: Amalgam Rx (iSage Rx) Secures USD0.65 Million in Venture Financing 147
Table 98: MuscleSound Raises USD0.8 Million in Venture Financing 148
Table 99: Informed Data Systems (One Drop) Raises USD40 Million in Series B Financing 149
Table 100: TecMed Raises Funds through Venture Financing 150
Table 101: Thermalin Raises Additional USD12.2 Million in Venture Financing 151
Table 102: VivaChek Laboratories Raises Funds through Venture Financing 152
Table 103: POPS! Diabetes Care Secures USD6 Million in Series A Funding 153
Table 104: Beta Bionics Raises USD63 Million in Series B2 Financing 154
Table 105: Encellin Raises USD1.6 Million in Venture Financing 156
Table 106: Eccrine Systems Raises USD0.6 Million in Venture Financing 157
Table 107: PhysioLogic Devices to Raise USD3 Million in Venture Financing 158
Table 108: Intuity Medical (Rosedale Medical) Raises USD26.27 Million in Venture Financing 159
Table 109: Mighty Well Raises Funds through Venture Financing 160

List of Figures
Figure 1: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 11
Figure 2: Diabetes Care Devices Market, United States, Revenue Mix ($m), 2019 13
Figure 3: Diabetes Care Devices Market, United States, Category Contribution (%), 2019 14
Figure 4: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Historic, 2015-2025 15
Figure 5: Diabetes Care Devices Market, United States, Volume (Units), 2015-2025 17
Figure 6: Diabetes Care Devices Market, United States, Volume (Units), Historic, 2015-2025 19
Figure 7: Diabetes Care Devices Market, United States, Company Share (%) 2019 21
Figure 8: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2015-2025 23
Figure 9: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, 2015-2025 25
Figure 10: Glucose Monitoring Market, United States, Volume (Units), 2015-2025 27
Figure 11: Blood Glucose Meters Market, United States, Volume (Units), 2015-2025 29
Figure 12: Glucose Monitoring Market, United States, Company Share (%) 2019 33
Figure 13: Insulin Delivery Market, United States, Revenue Mix ($m), 2019 34
Figure 14: Insulin Delivery Market, United States, Segment Contribution (%), 2019 35
Figure 15: Insulin Delivery Market, United States, Revenue ($m), USD Constant, 2015-2025 36
Figure 16: Insulin Pens Market, United States, Revenue ($m), USD Constant, 2015-2025 38
Figure 17: Insulin Pumps Market, United States, Revenue ($m), USD Constant, 2015-2025 40
Figure 18: Insulin Delivery Market, United States, Volume (Units), 2015-2025 42
Figure 19: Insulin Pens Market, United States, Volume (Units), 2015-2025 44
Figure 20: Insulin Pumps Market, United States, Volume (Units), 2015-2025 46
Figure 21: Insulin Delivery Market, United States, Company Share (%) 2019 50

Companies Mentioned
- DexCom Inc
- Medtronic Plc
- Novo Nordisk AS